First National Trust Co Sells 495 Shares of Aflac Incorporated (NYSE:AFL)

First National Trust Co reduced its stake in Aflac Incorporated (NYSE:AFL) by 0.7% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 69,084 shares of the financial services provider’s stock after selling 495 shares during the quarter. First National Trust Co’s holdings in Aflac were worth $7,146,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently modified their holdings of the stock. Franklin Resources Inc. lifted its holdings in shares of Aflac by 75.2% during the 3rd quarter. Franklin Resources Inc. now owns 776,131 shares of the financial services provider’s stock worth $88,533,000 after acquiring an additional 333,083 shares during the period. Aptus Capital Advisors LLC lifted its holdings in shares of Aflac by 79.7% in the third quarter. Aptus Capital Advisors LLC now owns 27,354 shares of the financial services provider’s stock worth $3,058,000 after acquiring an additional 12,131 shares during the last quarter. Transamerica Financial Advisors Inc. acquired a new stake in shares of Aflac in the 3rd quarter valued at approximately $979,000. Roxbury Financial LLC bought a new stake in shares of Aflac during the 4th quarter valued at approximately $948,000. Finally, FMR LLC lifted its stake in Aflac by 4.0% in the 3rd quarter. FMR LLC now owns 1,202,104 shares of the financial services provider’s stock valued at $134,395,000 after purchasing an additional 45,745 shares during the last quarter. 67.44% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In related news, Director Charles D. Lake II sold 29,802 shares of the firm’s stock in a transaction that occurred on Monday, March 10th. The shares were sold at an average price of $107.29, for a total value of $3,197,456.58. Following the completion of the transaction, the director now directly owns 49,962 shares of the company’s stock, valued at approximately $5,360,422.98. This trade represents a 37.36 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Joseph L. Moskowitz sold 1,000 shares of the firm’s stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $107.63, for a total value of $107,630.00. Following the completion of the transaction, the director now owns 25,393 shares of the company’s stock, valued at approximately $2,733,048.59. This represents a 3.79 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 55,546 shares of company stock valued at $5,863,616 over the last ninety days. 0.90% of the stock is currently owned by insiders.

Aflac Trading Up 0.3 %

Shares of AFL stock opened at $104.95 on Friday. Aflac Incorporated has a 52-week low of $79.31 and a 52-week high of $115.50. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.08 and a current ratio of 0.10. The company has a 50-day simple moving average of $105.29 and a two-hundred day simple moving average of $107.69. The company has a market capitalization of $57.37 billion, a price-to-earnings ratio of 10.93, a PEG ratio of 3.24 and a beta of 0.93.

Aflac (NYSE:AFL) last announced its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. Research analysts anticipate that Aflac Incorporated will post 6.88 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts have weighed in on the stock. StockNews.com raised shares of Aflac from a “sell” rating to a “hold” rating in a research note on Friday, February 14th. Wells Fargo & Company reduced their price target on Aflac from $104.00 to $102.00 and set an “equal weight” rating on the stock in a report on Wednesday, February 19th. BMO Capital Markets started coverage on shares of Aflac in a report on Thursday, January 23rd. They issued a “market perform” rating and a $111.00 price objective for the company. Piper Sandler dropped their price target on shares of Aflac from $122.00 to $118.00 and set an “overweight” rating for the company in a research note on Friday, February 7th. Finally, Keefe, Bruyette & Woods dropped their price target on shares of Aflac from $107.00 to $104.00 and set a “market perform” rating for the company in a research note on Wednesday, February 12th. Two investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $103.36.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.